DesRosier Thomas
See Remarks
DesRosier Thomas has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, DesRosier Thomas is listed as See Remarks at Seres Therapeutics, Inc. Inside the rolling window, DesRosier Thomas reported no open-market purchases and 4 open-market sales totaling $3K in MCRB. The largest disclosed transaction in the window is a sale of 76 MCRB shares on Nov 15, 2025, worth $1K.
Companies traded
Other insiders at MCRB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DesRosier Thomas made?
DesRosier Thomas has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does DesRosier Thomas trade?
DesRosier Thomas has filed SEC Form 4 disclosures for 1 company, including MCRB.
When was DesRosier Thomas's most recent SEC Form 4 filing?
DesRosier Thomas's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is DesRosier Thomas's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, DesRosier Thomas is listed as See Remarks.
What is DesRosier Thomas's total buy and sell value in the current window?
Inside the rolling retention window, DesRosier Thomas bought $0 and sold $3K based on SEC Form 4 filings.
What was DesRosier Thomas's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 76 MCRB shares on 2025-11-15, worth $1K, per SEC Form 4 filings.